Fund profile
Tickers
QAAGZX, QAAHBX
Fund manager
Total assets
$742.04 mm
Liabilities
$2.39 mm
Net assets
$739.65 mm
Number of holdings
232.00
Top 200 of 232 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
LLY Lilly(Eli) & Co | 73.32 mm | 94.24 k shares | 9.91 | Common equity | Long | USA |
UNH Unitedhealth Group Inc | 45.24 mm | 91.45 k shares | 6.12 | Common equity | Long | USA |
ISRG Intuitive Surgical Inc | 30.68 mm | 76.87 k shares | 4.15 | Common equity | Long | USA |
MRK Merck & Co Inc | 30.07 mm | 227.85 k shares | 4.06 | Common equity | Long | USA |
TMO Thermo Fisher Scientific Inc. | 29.83 mm | 51.33 k shares | 4.03 | Common equity | Long | USA |
SYK Stryker Corp. | 26.89 mm | 75.14 k shares | 3.64 | Common equity | Long | USA |
ELV Elevance Health Inc | 26.28 mm | 50.67 k shares | 3.55 | Common equity | Long | USA |
DHR Danaher Corp. | 21.65 mm | 86.68 k shares | 2.93 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 19.83 mm | 20.60 k shares | 2.68 | Common equity | Long | USA |
VRTX Vertex Pharmaceuticals, Inc. | 15.52 mm | 37.13 k shares | 2.10 | Common equity | Long | USA |
ARGX Argen X SE | 14.80 mm | 37.58 k shares | 2.00 | Common equity | Long | Netherlands |
ASTRAZENECA PLC
|
14.74 mm | 217.53 k shares | 1.99 | Common equity | Long | UK |
Cigna Holding Co | 13.75 mm | 37.85 k shares | 1.86 | Common equity | Long | USA |
AMGN AMGEN Inc. | 11.86 mm | 41.70 k shares | 1.60 | Common equity | Long | USA |
NVO Novo Nordisk | 11.10 mm | 86.46 k shares | 1.50 | Common equity | Long | Denmark |
MOH Molina Healthcare Inc | 10.76 mm | 26.18 k shares | 1.45 | Common equity | Long | USA |
EW Edwards Lifesciences Corp | 9.79 mm | 102.44 k shares | 1.32 | Common equity | Long | USA |
ALNY Alnylam Pharmaceuticals Inc | 9.66 mm | 64.62 k shares | 1.31 | Common equity | Long | USA |
BPMC Blueprint Medicines Corp | 9.64 mm | 101.59 k shares | 1.30 | Common equity | Long | USA |
A Agilent Technologies Inc. | 7.96 mm | 54.73 k shares | 1.08 | Common equity | Long | USA |
PEN Penumbra Inc | 7.94 mm | 35.60 k shares | 1.07 | Common equity | Long | USA |
BDX Becton Dickinson & Co. | 7.91 mm | 31.96 k shares | 1.07 | Common equity | Long | USA |
HCA HCA Healthcare Inc | 7.82 mm | 23.43 k shares | 1.06 | Common equity | Long | USA |
BSX Boston Scientific Corp. | 7.56 mm | 110.37 k shares | 1.02 | Common equity | Long | USA |
ABMD Abiomed Inc | 5.67 mm | 17.42 k shares | 0.77 | Common equity | Long | USA |
NBIX Neurocrine Biosciences, Inc. | 5.22 mm | 37.84 k shares | 0.71 | Common equity | Long | USA |
DXCM Dexcom Inc | 4.92 mm | 35.46 k shares | 0.66 | Common equity | Long | USA |
BEIGENE LTD
|
4.75 mm | 30.40 k shares | 0.64 | Common equity | Long | Cayman Islands |
VEEV Veeva Systems Inc - Ordinary Shares | 4.74 mm | 20.47 k shares | 0.64 | Common equity | Long | USA |
WST West Pharmaceutical Services, Inc. | 4.72 mm | 11.92 k shares | 0.64 | Common equity | Long | USA |
BIOHAVEN LTD
|
4.65 mm | 85.04 k shares | 0.63 | Common equity | Long | Virgin Islands (British) |
ASND Ascendis Pharma A/S | 4.47 mm | 29.59 k shares | 0.60 | Common equity | Long | Denmark |
HOLX Hologic, Inc. | 4.47 mm | 57.31 k shares | 0.60 | Common equity | Long | USA |
CNC Centene Corp. | 4.22 mm | 53.73 k shares | 0.57 | Common equity | Long | USA |
CAH Cardinal Health, Inc. | 4.11 mm | 36.76 k shares | 0.56 | Common equity | Long | USA |
ICON PLC
|
4.06 mm | 12.10 k shares | 0.55 | Common equity | Long | Ireland |
ZTS Zoetis Inc - Ordinary Shares | 3.82 mm | 22.58 k shares | 0.52 | Common equity | Long | USA |
BIIB Biogen Inc | 3.78 mm | 17.53 k shares | 0.51 | Common equity | Long | USA |
MDGL Madrigal Pharmaceuticals Inc | 3.75 mm | 14.03 k shares | 0.51 | Common equity | Long | USA |
IMMUNOCORE HOLDINGS PLC
|
3.71 mm | 57.08 k shares | 0.50 | Common equity | Long | UK |
APLS Apellis Pharmaceuticals Inc | 3.69 mm | 62.85 k shares | 0.50 | Common equity | Long | USA |
ZBH Zimmer Biomet Holdings Inc | 3.64 mm | 27.59 k shares | 0.49 | Common equity | Long | USA |
TECH Bio-Techne Corp | 3.54 mm | 50.33 k shares | 0.48 | Common equity | Long | USA |
THC Tenet Healthcare Corp. | 3.46 mm | 32.90 k shares | 0.47 | Common equity | Long | USA |
SWTX SpringWorks Therapeutics Inc | 3.46 mm | 70.22 k shares | 0.47 | Common equity | Long | USA |
HUM Humana Inc. | 3.44 mm | 9.93 k shares | 0.47 | Common equity | Long | USA |
MCK Mckesson Corporation | 3.41 mm | 6.36 k shares | 0.46 | Common equity | Long | USA |
ABBV Abbvie Inc | 3.40 mm | 18.69 k shares | 0.46 | Common equity | Long | USA |
NATIONAL RESILIENCE SER B CVT PFD STOCK | 3.29 mm | 54.25 k shares | 0.45 | Preferred equity | Long | USA |
TXG 10x Genomics Inc - Ordinary Shares | 3.28 mm | 87.43 k shares | 0.44 | Common equity | Long | USA |
KRYS Krystal Biotech Inc | 3.24 mm | 18.20 k shares | 0.44 | Common equity | Long | USA |
BMRN Biomarin Pharmaceutical Inc. - Registered Shares | 3.10 mm | 35.52 k shares | 0.42 | Common equity | Long | USA |
LEGN Legend Biotech Corp | 2.99 mm | 53.35 k shares | 0.40 | Common equity | Long | Cayman Islands |
IQV IQVIA Holdings Inc | 2.94 mm | 11.63 k shares | 0.40 | Common equity | Long | USA |
RARE Ultragenyx Pharmaceutical Inc. | 2.88 mm | 61.72 k shares | 0.39 | Common equity | Long | USA |
CRL Charles River Laboratories International Inc. | 2.81 mm | 10.39 k shares | 0.38 | Common equity | Long | USA |
APGE Apogee Therapeutics Inc. | 2.76 mm | 41.51 k shares | 0.37 | Common equity | Long | USA |
INSM Insmed Inc | 2.65 mm | 97.59 k shares | 0.36 | Common equity | Long | USA |
CLDX Celldex Therapeutics Inc. | 2.63 mm | 62.76 k shares | 0.36 | Common equity | Long | USA |
MLTX MoonLake Immunotherapeutics - Ordinary Shares | 2.49 mm | 49.65 k shares | 0.34 | Common equity | Long | Cayman Islands |
KYMR Kymera Therapeutics Inc | 2.45 mm | 61.05 k shares | 0.33 | Common equity | Long | USA |
EXAS Exact Sciences Corp. | 2.45 mm | 35.47 k shares | 0.33 | Common equity | Long | USA |
TEMPUS LABS INC CVT PFD SR D PP | 2.42 mm | 56.86 k shares | 0.33 | Preferred equity | Long | USA |
RVMD Revolution Medicines Inc | 2.30 mm | 71.26 k shares | 0.31 | Common equity | Long | USA |
ARVN Arvinas Inc | 2.30 mm | 55.60 k shares | 0.31 | Common equity | Long | USA |
RGEN Repligen Corp. | 2.24 mm | 12.16 k shares | 0.30 | Common equity | Long | USA |
COR Cencora Inc. | 2.14 mm | 8.80 k shares | 0.29 | Common equity | Long | USA |
BRKR Bruker Corp | 2.13 mm | 22.69 k shares | 0.29 | Common equity | Long | USA |
AVIDITY BIOSCIENCES INC PIPE PP
|
2.09 mm | 86.12 k shares | 0.28 | Common equity | Long | USA |
IOVA Iovance Biotherapeutics Inc | 2.01 mm | 135.67 k shares | 0.27 | Common equity | Long | USA |
T. Rowe Price Government Reserve Fund | 1.91 mm | 1.91 mm shares | 0.26 | Short-term investment vehicle | Long | USA |
INSP Inspire Medical Systems Inc | 1.87 mm | 8.72 k shares | 0.25 | Common equity | Long | USA |
SARTORIUS AG | 1.85 mm | 4.66 k shares | 0.25 | Preferred equity | Long | Germany |
IMNM Immunome Inc | 1.76 mm | 71.45 k shares | 0.24 | Common equity | Long | USA |
TEMPUS LAB SERIES E CVT PFD STOCK PP | 1.69 mm | 37.55 k shares | 0.23 | Preferred equity | Long | USA |
SRPT Sarepta Therapeutics Inc | 1.65 mm | 12.71 k shares | 0.22 | Common equity | Long | USA |
IONS Ionis Pharmaceuticals Inc | 1.63 mm | 37.56 k shares | 0.22 | Common equity | Long | USA |
SRRK Scholar Rock Holding Corp | 1.56 mm | 87.87 k shares | 0.21 | Common equity | Long | USA |
PRCT Procept BioRobotics Corp | 1.55 mm | 31.28 k shares | 0.21 | Common equity | Long | USA |
DAIICHI SANKYO CO LTD
|
1.51 mm | 47.30 k shares | 0.20 | Common equity | Long | Japan |
CYTK Cytokinetics Inc | 1.50 mm | 21.46 k shares | 0.20 | Common equity | Long | USA |
RNA Avidity Biosciences Inc | 1.48 mm | 58.18 k shares | 0.20 | Common equity | Long | USA |
GPCR Structure Therapeutics Inc | 1.40 mm | 32.64 k shares | 0.19 | Common equity | Long | Cayman Islands |
PODD Insulet Corporation | 1.36 mm | 7.94 k shares | 0.18 | Common equity | Long | USA |
ALPN Alpine Immune Sciences Inc | 1.31 mm | 33.01 k shares | 0.18 | Common equity | Long | USA |
SANA Sana Biotechnology Inc | 1.26 mm | 126.17 k shares | 0.17 | Common equity | Long | USA |
MORF Morphic Holding Inc | 1.26 mm | 35.78 k shares | 0.17 | Common equity | Long | USA |
NOVOCURE LTD
|
1.22 mm | 78.26 k shares | 0.17 | Common equity | Long | Jersey |
NATIONAL RESILIENCE SER C CVT PFD STOCK | 1.17 mm | 19.22 k shares | 0.16 | Preferred equity | Long | USA |
RCKT Rocket Pharmaceuticals Inc | 1.17 mm | 43.26 k shares | 0.16 | Common equity | Long | USA |
SGRY Surgery Partners Inc | 1.15 mm | 38.60 k shares | 0.16 | Common equity | Long | USA |
LNTH Lantheus Holdings Inc | 1.06 mm | 17.07 k shares | 0.14 | Common equity | Long | USA |
AGIO Agios Pharmaceuticals Inc | 1.05 mm | 35.92 k shares | 0.14 | Common equity | Long | USA |
CRGX CARGO Therapeutics Inc | 1.01 mm | 45.27 k shares | 0.14 | Common equity | Long | USA |
GENERATE BIO SER B CVT PFD STOCK PP | 1.00 mm | 84.49 k shares | 0.14 | Preferred equity | Long | USA |
ARDX Ardelyx Inc | 992.80 k | 136.00 k shares | 0.13 | Common equity | Long | USA |
EIKON THERA SERIES B CVT PFD STOCK PP | 984.25 k | 45.78 k shares | 0.13 | Preferred equity | Long | USA |
DNLI Denali Therapeutics Inc | 980.90 k | 47.80 k shares | 0.13 | Common equity | Long | USA |
ZAI LAB LTD
|
980.76 k | 61.22 k shares | 0.13 | Common equity | Long | Cayman Islands |
ZNTL Zentalis Pharmaceuticals Inc | 928.14 k | 58.89 k shares | 0.13 | Common equity | Long | USA |
EXEL Exelixis Inc | 919.49 k | 38.75 k shares | 0.12 | Common equity | Long | USA |
SIEMENS HEALTHINEERS AG
|
914.24 k | 14.95 k shares | 0.12 | Common equity | Long | Germany |
PTGX Protagonist Therapeutics Inc | 902.62 k | 31.20 k shares | 0.12 | Common equity | Long | USA |
LBPH Longboard Pharmaceuticals Inc | 899.51 k | 41.64 k shares | 0.12 | Common equity | Long | USA |
XNCR Xencor Inc | 881.75 k | 39.84 k shares | 0.12 | Common equity | Long | USA |
AKRO Akero Therapeutics Inc | 864.14 k | 34.21 k shares | 0.12 | Common equity | Long | USA |
CARGO THERAPEUTICS | 848.27 k | 38.01 k shares | 0.11 | Preferred equity | Long | USA |
TREELINE BIO SER A CVT PFD STOCK PP | 830.19 k | 106.06 k shares | 0.11 | Preferred equity | Long | USA |
INCY Incyte Corp. | 818.32 k | 14.36 k shares | 0.11 | Common equity | Long | USA |
RLAY Relay Therapeutics Inc | 816.88 k | 98.42 k shares | 0.11 | Common equity | Long | USA |
IMMUNOCORE HOLDINGS PLC | 771.52 k | 739.00 k principal | 0.10 | Debt | Long | UK |
PROTHENA CORP PLC
|
764.33 k | 30.86 k shares | 0.10 | Common equity | Long | Ireland |
DELFI DIAGNOSTICS SR A CVT PFD STOCK PP | 748.76 k | 154.53 k shares | 0.10 | Preferred equity | Long | USA |
INSITRO SER B CVT PFD PP | 727.86 k | 39.79 k shares | 0.10 | Preferred equity | Long | USA |
IMTX Immatics N.V | 713.60 k | 67.90 k shares | 0.10 | Common equity | Long | Netherlands |
CNTA Centessa Pharmaceuticals plc | 710.68 k | 62.89 k shares | 0.10 | Common equity | Long | UK |
ELEMENT BIOSCIENCES SER C CVT PFD STOCK | 702.40 k | 38.79 k shares | 0.09 | Preferred equity | Long | USA |
CELLANOME SERIES A CVT PFD STOCK PP | 672.89 k | 89.84 k shares | 0.09 | Preferred equity | Long | USA |
SPYRE THERAPEUTICS CVT PFD PIPE STOCK PP | 665.90 k | 462.00 shares | 0.09 | Preferred equity | Long | USA |
GH Guardant Health Inc | 636.41 k | 30.85 k shares | 0.09 | Common equity | Long | USA |
CARIS LIFE SCIENCES SER C CVT PFD PP | 616.17 k | 169.28 k shares | 0.08 | Preferred equity | Long | USA |
CHROMA MEDICINE SERIES A CVT PFD STOCK P | 613.02 k | 235.78 k shares | 0.08 | Preferred equity | Long | USA |
ACAD Acadia Pharmaceuticals Inc | 548.88 k | 29.69 k shares | 0.07 | Common equity | Long | USA |
ALLO Allogene Therapeutics Inc | 545.10 k | 121.95 k shares | 0.07 | Common equity | Long | USA |
REPL Replimune Group Inc | 544.64 k | 66.66 k shares | 0.07 | Common equity | Long | USA |
LYEL Lyell Immunopharma Inc | 538.99 k | 241.70 k shares | 0.07 | Common equity | Long | USA |
SAGE Sage Therapeutics Inc | 533.79 k | 28.48 k shares | 0.07 | Common equity | Long | USA |
FREENOME HOLDINGS SER B CVT PFD PP | 528.24 k | 71.40 k shares | 0.07 | Preferred equity | Long | USA |
PROGNOMIQ SER B CVT PFD STOCK | 514.15 k | 168.02 k shares | 0.07 | Preferred equity | Long | USA |
VERILY LIFE SCIENCES LLC SER B UNITS PP
|
509.16 k | 5.22 k shares | 0.07 | Common equity | Long | USA |
NUTCRACKER THERA SER C CVT PFD STOCK PP | 500.66 k | 46.57 k shares | 0.07 | Preferred equity | Long | USA |
SALIOGEN THERA SERIES B CVT PFD STOCK PP | 496.50 k | 4.69 k shares | 0.07 | Preferred equity | Long | USA |
KARTOS THERAPEUTICS SR C CVT PFD STK PP | 485.75 k | 85.93 k shares | 0.07 | Preferred equity | Long | USA |
INSITRO SER C CVT PFD PP | 480.73 k | 26.28 k shares | 0.06 | Preferred equity | Long | USA |
KARDIUM SERIES D6 CVT PFD STOCK PP | 473.03 k | 556.50 k shares | 0.06 | Preferred equity | Long | USA |
GENESIS THERA SEV B CVT PFD STOCK PP | 465.32 k | 91.10 k shares | 0.06 | Preferred equity | Long | USA |
IGMS IGM Biosciences Inc | 429.07 k | 44.46 k shares | 0.06 | Common equity | Long | USA |
OBSIDIAN THERAPEUTICS SR C CVT PFD STK PP | 422.06 k | 222.39 k shares | 0.06 | Preferred equity | Long | USA |
PROFOUNDBIO SERIES B CVT PFD STOCK PP | 420.84 k | 56.31 k shares | 0.06 | Preferred equity | Long | USA |
PLRX Pliant Therapeutics Inc | 410.30 k | 27.54 k shares | 0.06 | Common equity | Long | USA |
DELFI DIAGNOSTICS SR B CVT PFD STOCK PP | 407.53 k | 84.10 k shares | 0.06 | Preferred equity | Long | USA |
RAPPORT THERAPEUTICS SR B CVT PFD STK PP | 404.21 k | 241.00 k shares | 0.05 | Preferred equity | Long | USA |
RING THERA SER B CVT PFD STOCK PP | 403.74 k | 43.89 k shares | 0.05 | Preferred equity | Long | USA |
VYGR Voyager Therapeutics Inc | 398.57 k | 42.81 k shares | 0.05 | Common equity | Long | USA |
END EAVOR BIO SERIES B CVT PFD STOCK PP | 397.59 k | 84.30 k shares | 0.05 | Preferred equity | Long | USA |
ARBOR BIO SERIES B CVT PFD STOCK PP | 397.58 k | 23.99 k shares | 0.05 | Preferred equity | Long | USA |
BCYC Bicycle Therapeutics Plc | 381.07 k | 15.30 k shares | 0.05 | Common equity | Long | UK |
CARIS LIFE SER D CVT PFD STOCK PP | 371.06 k | 101.94 k shares | 0.05 | Preferred equity | Long | USA |
TEMPUS LABS SERIES F CVT PFD STOCK PP | 369.16 k | 7.94 k shares | 0.05 | Preferred equity | Long | USA |
GLUE Monte Rosa Therapeutics Inc | 365.34 k | 51.82 k shares | 0.05 | Common equity | Long | USA |
TESSERA THERAPEUTICS SR C CVT PFD STK PP | 357.36 k | 17.48 k shares | 0.05 | Preferred equity | Long | USA |
DNA SCRIPT SERIES C CVT PFD STOCK PP | 352.31 k | 1.13 k shares | 0.05 | Preferred equity | Long | France |
KARDIUM INC SER D-5 CVT PFD STOCK PP | 343.21 k | 403.78 k shares | 0.05 | Preferred equity | Long | USA |
TFX Teleflex Incorporated | 311.21 k | 1.38 k shares | 0.04 | Common equity | Long | USA |
FREENOME HOLDINGS SER C CVT PFD PP | 308.76 k | 41.73 k shares | 0.04 | Preferred equity | Long | USA |
CFRXQ CONTRAFECT Corp | 305.08 k | 81.35 k shares | 0.04 | Common equity | Long | USA |
GALVANIZE THERAPEUTICS CVT PROM NOTE PP | 295.30 k | 295.30 k principal | 0.04 | Debt | Long | USA |
COLOR HEALTH SERIES D-1 CVT PFD STOCK PP | 290.78 k | 20.17 k shares | 0.04 | Preferred equity | Long | USA |
AVALYN PHARMA SER C-1 CVT PFD STOCK PP | 284.58 k | 388.60 k shares | 0.04 | Preferred equity | Long | USA |
TRDA Entrada Therapeutics Inc | 281.33 k | 19.85 k shares | 0.04 | Common equity | Long | USA |
AGL Agilon Health Inc | 279.48 k | 45.82 k shares | 0.04 | Common equity | Long | USA |
SCRIBE THERA SER B CVT PFD STOCK PP | 277.64 k | 45.88 k shares | 0.04 | Preferred equity | Long | USA |
SALUDA MEDICAL SERIES D CVT PFD STOCK PP | 276.58 k | 31.15 k shares | 0.04 | Preferred equity | Long | USA |
NUVL Nuvalent Inc - Ordinary Shares | 269.50 k | 3.59 k shares | 0.04 | Common equity | Long | USA |
ODYSSEY THERAPEUTICS SR B CVT PFD STK PP | 262.95 k | 50.57 k shares | 0.04 | Preferred equity | Long | USA |
REFLEXION MEDICAL INC CVT PFD SR C PP | 259.22 k | 150.71 k shares | 0.04 | Preferred equity | Long | USA |
COLOR HEALTH SER D CVT PFD STOCK PP | 257.02 k | 13.31 k shares | 0.03 | Preferred equity | Long | USA |
TEMPUS LAB SERIES G CVT PFD | 247.64 k | 5.11 k shares | 0.03 | Preferred equity | Long | USA |
HONOR TECHNOLOGY SER D CVT PFD PP | 240.82 k | 140.83 k shares | 0.03 | Preferred equity | Long | USA |
SIONNA THERAPEUTICS SR B CVT PFD STK PP | 238.77 k | 24.46 k shares | 0.03 | Preferred equity | Long | USA |
CLEERLY SER C CVT PFD STK PP | 238.00 k | 26.53 k shares | 0.03 | Preferred equity | Long | USA |
LARONDE SERIES B CVT PFD STOCK PP | 220.66 k | 52.54 k shares | 0.03 | Preferred equity | Long | USA |
GBIO Generation Bio Co | 208.21 k | 51.16 k shares | 0.03 | Common equity | Long | USA |
TEMPUS LABS SERIES G-2 CVT PFD STOCK PP | 204.56 k | 5.28 k shares | 0.03 | Preferred equity | Long | USA |
FOG PHARMA SER D CVT PFD STOCK PP | 202.26 k | 27.55 k shares | 0.03 | Preferred equity | Long | USA |
GENERATE BIOMEDICINES INC SER C CVT PFD | 201.49 k | 17.00 k shares | 0.03 | Preferred equity | Long | USA |
LUMICKS TECH SER D CVT PFD STOCK PP | 200.52 k | 221.00 shares | 0.03 | Preferred equity | Long | USA |
AFFINIVAX AFX3772 MILESTONE EVENT PP
|
199.19 k | 331.98 k shares | 0.03 | Common equity | Long | USA |
CHROMA MEDICINE SER B CVT PFT STOCK PP | 197.85 k | 76.10 k shares | 0.03 | Preferred equity | Long | USA |
RING THERAPEUTICS SER C CVT PFD STK PP | 197.63 k | 21.48 k shares | 0.03 | Preferred equity | Long | USA |
SALUDA MEDICAL INC SERIES E CVT PFD PP | 196.03 k | 24.28 k shares | 0.03 | Preferred equity | Long | USA |
EIKON THERAPEUTICS SER C CVT PFD STK PP | 195.04 k | 9.07 k shares | 0.03 | Preferred equity | Long | USA |
GENESIS THERA SER A CVT PFD STOCK PP | 191.39 k | 37.47 k shares | 0.03 | Preferred equity | Long | USA |
PRLD Prelude Therapeutics Inc | 187.46 k | 39.55 k shares | 0.03 | Common equity | Long | USA |
ALEC Alector Inc | 182.90 k | 30.38 k shares | 0.02 | Common equity | Long | USA |
FREENOME HOLDINGS SER D CVT PFD PP | 175.56 k | 23.67 k shares | 0.02 | Preferred equity | Long | USA |
FOG PHARMACEUTICALS SERIES C CVT PFD STOCK PP | 165.37 k | 19.48 k shares | 0.02 | Preferred equity | Long | USA |
NTLA Intellia Therapeutics Inc | 164.32 k | 5.97 k shares | 0.02 | Common equity | Long | USA |
HONOR TECHNOLOGY SER E CVT PFD STOCK PP | 162.31 k | 94.92 k shares | 0.02 | Preferred equity | Long | USA |
PRME Prime Medicine Inc | 158.42 k | 22.63 k shares | 0.02 | Common equity | Long | USA |
PROGNOMIQ SER C CVT PFD STOCK PP | 157.49 k | 51.47 k shares | 0.02 | Preferred equity | Long | USA |
PAX LABS CLASS A COMMON PP
|
154.27 k | 385.68 k shares | 0.02 | Common equity | Long | USA |
REFLEXION MEDICAL INC SR E CVT PFD PP | 150.94 k | 83.86 k shares | 0.02 | Preferred equity | Long | USA |
ANAB AnaptysBio Inc | 141.88 k | 6.30 k shares | 0.02 | Common equity | Long | USA |
AURA Aura Biosciences Inc | 140.28 k | 17.87 k shares | 0.02 | Common equity | Long | USA |
OBIO Orchestra BioMed Holdings Inc | 130.61 k | 24.78 k shares | 0.02 | Common equity | Long | USA |
INSCRIPTA SERIES E CVT PFD STOCK PP | 121.06 k | 64.74 k shares | 0.02 | Preferred equity | Long | USA |
CRISPR THERAPEUTICS AG
|
116.14 k | 1.70 k shares | 0.02 | Common equity | Long | Switzerland |
REFLEXION MEDICAL INC PP | 109.93 k | 83.28 k shares | 0.01 | Preferred equity | Long | USA |
CLEAR LABS SERIES C CVT PFD PP | 106.29 k | 171.44 k shares | 0.01 | Preferred equity | Long | USA |